Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| The Finnish Funding Agency for Technology and Innovation | OTHER_GOV |
Aim of this study is to investigate the effects of intake of sea buckthorn oil on mucous membranes
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Sea buckthorn oil | Experimental | 3 g (6 capsules)/day for three months |
|
| Placebo oil | Placebo Comparator | 3 g (6 capsules)/day for three months |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Sea buckthorn oil | Dietary Supplement |
| ||
| Placebo oil |
| Measure | Description | Time Frame |
|---|---|---|
| Change from baseline in dryness related symptoms of genital mucous membranes | Interview for symptom score at baseline and study visits and a daily symptom logbook during the intervention | Interviews at baseline, at 2 months, at 3 moths (end of intervention), and daily during the study (symptom logbooks) |
| Measure | Description | Time Frame |
|---|---|---|
| Change from baseline in vaginal pH | At baseline, at 3 months (end of intervention) |
| Measure | Description | Time Frame |
|---|---|---|
| Change from baseline in vaginal health index, vaginal dryness, vaginal maturity index, symptoms of dryness in other mucous membranes, markers of inflammation, oxidative stress and metabolic disorder in the circulation |
|
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Risto Erkkola, Professor | Turun Gynekologikeskus, Turku, Finland | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Turun Gynekologikeskus | Turku | 20100 | Finland |
Not provided
Not provided
| ID | Type | URL | Comment |
|---|---|---|---|
| Clinical Study Report | View IPD |
Not provided
| ID | Term |
|---|---|
| D024821 | Metabolic Syndrome |
| ID | Term |
|---|---|
| D007333 | Insulin Resistance |
| D006946 | Hyperinsulinism |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| At baseline, at 3 months (end of intervention) |
| D009750 |
| Nutritional and Metabolic Diseases |